title: [Posterior fossa hemorrhage in newborns following vaccum extractor delivery].
abstract: OBJECTIVE
  To emphasize the risk of posterior fossa hemorrhage in newborns following vacuum extraction.
  
  
  METHODS
  Over a period of 26 months (September 1996-December 1998), seven patients who underwent delivery with the vacuum extractor had symptoms of brain stem compression, related to posterior fossa hemorrhage. They were referred to the neonatal intensive care unit. Some parameters had been analyzed: gestational period, delivery circumstances, gestational age, parameters of newborn, indications of vacuum extraction and other paraclinical investigations (biological and radiological).
  
  
  RESULTS
  Ultrasound scan revealed intracranial hemorrhage in five cases of seven; mean time of diagnosis was 10 hours of age. All patients presented symptoms of brain stem compression. Mean period of follow-up was 22 months: six of seven patients had a normal neurodevelopment. One patient had a cerebellar ataxia, another one a palsy of the IIIrd cranial nerve.
  
  
  CONCLUSIONS
  Analyses of posterior fossa by ultrasound scan should be made for newborns delivered by vacuum extractor, especially if they had symptoms of brain stem compression.
authors.affiliation: Centre hospitalier de Verdun, service de pédiatrie, BP 713, 55107 Verdun, France. h.ezzeddine@hotmail.com
authors.forename: H
authors.initials: H
authors.lastname: Ezzeddine
authors.forename: N
authors.initials: N
authors.lastname: Bednarek
authors.forename: B
authors.initials: B
authors.lastname: Leroux
authors.forename: P
authors.initials: P
authors.lastname: Morville
mesh_terms: D001933:Brain Stem / Q000473:pathology*; D002524:Cerebellar Ataxia / Q000209:etiology; D003389:Cranial Nerve Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D020300:Intracranial Hemorrhages / Q000150:complications / Q000000981:diagnostic imaging / Q000209:etiology*; D008297:Male; D014463:Ultrasonography; D014620:Vacuum Extraction, Obstetrical / Q000009:adverse effects*